Skip to main content
. 2016 Dec 9;11:160. doi: 10.1186/s13012-016-0516-1

Table 3.

Effects on clinical performance measured by 11 care processes and six patient outcomes (primary outcome) (n = 14,874)

Care processes and patient outcomes Type Control group Intervention group P value
Crude baseline performance Crude follow-up performance Adjusted performance trend [OR (95% CI)] Crude baseline performance Crude follow-up performance Adjusted performance trend [OR (95% CI)]
Psychosocial rehabilitation (study group A)
 1. Complete data on psychological functioning Process 69.0% (623/903) 68.3% (3134/4591) 0.64 (0.32 to 1.28) 86.1% (1733/2012) 84.7% (6217/7341) 0.69 (0.42 to 1.11) 0.872
 2. Complete data on social functioning Process 16.1% (145/903) 15.5% (712/4591) 0.17 (0.01 to 2.06) 53.2% (1071/2012) 56.4% (4142/7341) 1.36 (0.05 to 3.71) 0.130
 3. Complete data on lifestyle factors Process 82.8% (748/903) 84.6% (3885/4591) 0.92 (0.46 to 1.85) 86.1% (1733/2012) 80.2% (5884/7341) 1.03 (0.57 to 1.86) 0.815
 4. Disease specific education completeda Process 51.3% (424/827) 44.1% (1796/4071) 0.76 (0.48 to 1.20) 62.7% (842/1342) 61.7% (3046/4934) 0.44 (0.29 to 0.67) 0.091
 5. Lifestyle modification programme completeda Process 41.3% (373/903) 40.8% (1874/4591) 1.08 (0.63 to 1.85) 55.7% (877/1575) 58.3% (3255/5580) 1.34 (0.78 to 2.31) 0.385
 6. Improved quality of live after CR Outcome 44.6% (403/903) 46.5% (2133/4591) 0.99 (0.86 to 1.13) 41.0% (826/2012) 43.5% (3193/7341) 1 (0.89 to 1.12) 0.571
 7. Successful smoking cessation Outcome 56.0% (506/903) 54.2% (2489/4591) 0.96 (0.84 to 1.09) 49.5% (996/2012) 51.1% (3752/7341) 0.99 (0.89 to 1.11) 0.553
 8. Patients receive a discharge letter with remaining lifestyle goals Process 13.1% (118/903) 19.9% (914/4591) 5.39 (2.14 to 13.56) 27.3% (549/2012) 28.9% (2120/7341) 4.61 (2.29 to 9.30) 0.764
Physical rehabilitation (study group B)
 9. Complete data on physical functioning Process 54.5% (1097/2012) 61.8% (4534/7341) 1.35 (0.72 to 2.54) 52.6% (475/903) 65.6% (3010/4591) 1.78 (0.75 to 4.20) 0.611
 10. Complete data concerning cardiovascular risk factors Process 55.3% (1112/2012) 49.8% (3656/7341) 1.12 (0.76 to 1.65) 54.4% (491/903) 60.4% (2775/4591) 1.34 (0.83 to 2.17) 0.562
 11. Exercise training completeda Process 53.4% (1074/2012) 45.9% (3366/7341) 0.44 (0.27 to 0.74) 65.8% (421/640) 60.9% (1780/2922) 0.8 (0.29 to 2.21) 0.374
 12. Relaxation and stress management training completeda Process 43.6% (666/1528) 48.3% (2367/4898) 2.47 (1.25 to 4.88) 44.7% (370/827) 45.8% (1863/4071) 1.04 (0.40 to 2.71) 0.183
 13. Cardiovascular risk factors evaluated at discharge Process 10.3% (208/2012) 7.4% (541/7341) 0.87 (0.41 to 1.83) 32.7% (295/903) 29.9% (1373/4591) 1.01 (0.43 to 2.37) 0.667
 14. Improvement in exercise capacity Outcome 46.5% (936/2012) 51.3% (3769/7341) 1.28 (1.11 to 1.47) 50.2% (453/903) 49.7% (2280/4591) 1.12 (0.91 to 1.38) 0.248
 15. Successful work resumption Outcome 53.3% (1072/2012) 52.4% (3848/7341) 0.93 (0.83 to 1.05) 65.7% (593/903) 68.5% (3146/4591) 0.97 (0.84 to 1.12) 0.448
 16. Moderately active lifestyle norm met at discharge Outcome 37.1% (747/2012) 35.7% (2621/7341) 0.96 (0.83 to 1.11) 71.8% (648/903) 72.8% (3340/4591) 1 (0.85 to 1.17) 0.633
 17. Vigorously active lifestyle norm met at discharge Outcome 22.1% (444/2012) 30.8% (2263/7341) 1.29 (1.15 to 1.45) 26.8% (242/903) 28.1% (1292/4591) 1.13 (0.99 to 1.30) 0.200

We used Multiple Imputation by Chained Equations to handle missing data. Baseline period: first 3 months of study period; follow-up period: complete study period minus the baseline period. Performance trends: odds ratios associated with a 1-year study follow-up, adjusted for patients’ age, gender, indication for CR, and centres’ type and size. P value: probability of trends being similar in intervention and control group

Abbreviations: CI confidence interval, CR cardiac rehabilitation, OR odds ratio

aWe excluded centres with incomplete data for this indicator. The number of centres and patients included in the analyses was therefore as follows: indicator 4: 12 centres, 11,174 patients; indicator 5: 15 centres, 12,649 patients; indicator 11: 16 centres, 12,915 patients; and indicator 12: 15 centres, 11,324 patients